NCT01308684 A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT01307397 A Study of Vemurafenib in Participants With Metastatic Melanoma Status COMPLETED Phase PHASE3
NCT01303029 Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01302600 Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients. Status COMPLETED Phase PHASE2
NCT01301729 A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment Status COMPLETED Phase PHASE4
NCT01297127 Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection Status COMPLETED Phase N/A
NCT01296971 A Study of the Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER) Status WITHDRAWN Phase PHASE3
NCT01292603 A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE1
NCT01292226 A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil). Status COMPLETED Phase PHASE2
NCT01290718 A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. Status TERMINATED Phase PHASE2
NCT01290094 A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis Status COMPLETED Phase PHASE3
NCT01289496 Ribavirin Dose Optimization for the Treatment of Hepatitis C Status COMPLETED Phase PHASE2
NCT01287754 A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations Status COMPLETED Phase PHASE4
NCT01287741 A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) Status TERMINATED Phase PHASE3
NCT01286753 A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation Status COMPLETED Phase PHASE2
NCT01283971 A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor Status TERMINATED Phase PHASE4